BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10581073)

  • 1. Runt domains take the lead in hematopoiesis and osteogenesis.
    Werner MH; Shigesada K; Ito Y
    Nat Med; 1999 Dec; 5(12):1356-7. PubMed ID: 10581073
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional mutagenesis of AML1/RUNX1 and PEBP2 beta/CBF beta define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain.
    Nagata T; Werner MH
    J Mol Biol; 2001 Apr; 308(2):191-203. PubMed ID: 11327761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
    Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia.
    Westendorf JJ; Hiebert SW
    J Cell Biochem; 1999; Suppl 32-33():51-8. PubMed ID: 10629103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
    Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
    Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
    Nagata T; Gupta V; Sorce D; Kim WY; Sali A; Chait BT; Shigesada K; Ito Y; Werner MH
    Nat Struct Biol; 1999 Jul; 6(7):615-9. PubMed ID: 10404214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX genes, neoplasia, and cleidocranial dysplasia.
    Cohen MM
    Am J Med Genet; 2001 Dec; 104(3):185-8. PubMed ID: 11754042
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional conservation of hematopoietic factors in Drosophila and vertebrates.
    Fossett N; Schulz RA
    Differentiation; 2001 Dec; 69(2-3):83-90. PubMed ID: 11798069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemia-associated AML1 (Runx1)--CBF beta complex functions as a DNA-induced molecular clamp.
    Bravo J; Li Z; Speck NA; Warren AJ
    Nat Struct Biol; 2001 Apr; 8(4):371-8. PubMed ID: 11276260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML-1 steps up to the platelets.
    Irvin BJ; Hiebert SW
    Nat Med; 2004 Mar; 10(3):238-9. PubMed ID: 14991045
    [No Abstract]   [Full Text] [Related]  

  • 11. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia.
    Zhang YW; Yasui N; Ito K; Huang G; Fujii M; Hanai J; Nogami H; Ochi T; Miyazono K; Ito Y
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10549-54. PubMed ID: 10962029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 14. Cleidocranial dysplasia with severe parietal bone dysplasia: C-terminal RUNX2 mutations.
    Cunningham ML; Seto ML; Hing AV; Bull MJ; Hopkin RJ; Leppig KA
    Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):78-85. PubMed ID: 16463420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of hematopoiesis by transcription factors].
    Kurokawa M; Hirai H
    Tanpakushitsu Kakusan Koso; 2000 Jun; 45(9 Suppl):1565-72. PubMed ID: 10879135
    [No Abstract]   [Full Text] [Related]  

  • 16. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium.
    Yan J; Liu Y; Lukasik SM; Speck NA; Bushweller JH
    Nat Struct Mol Biol; 2004 Sep; 11(9):901-6. PubMed ID: 15322525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upstream and downstream targets of RUNX proteins.
    Otto F; Lübbert M; Stock M
    J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new angle on a pervasive oncogene.
    Cleary ML
    Nat Genet; 1999 Oct; 23(2):134-5. PubMed ID: 10508502
    [No Abstract]   [Full Text] [Related]  

  • 19. Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
    Bloomfield CD; Ruppert AS; Mrózek K; Kolitz JE; Moore JO; Mayer RJ; Edwards CG; Sterling LJ; Vardiman JW; Carroll AJ; Pettenati MJ; Stamberg J; Byrd JC; Marcucci G; Larson RA;
    Ann Hematol; 2004; 83 Suppl 1():S84-5. PubMed ID: 15124687
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of leukemogenesis induced by AML 1-MTG 8].
    Kitabayashi I; Ohki M
    Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):26-32. PubMed ID: 10643332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.